Published in
Springer, Targeted Oncology, 6(17), p. 615-625, 2022
DOI: 10.1007/s11523-022-00913-x
Links
Tools
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study
Journal article published in 2022 by
Michelino De Laurentiis 
,
Roberta Caputo,
Manuelita Mazza,
Mauro Mansutti,
Riccardo Masetti,
Zelmira Ballatore,
Rosalba Torrisi ,
Andrea Michelotti,
Alberto Zambelli,
Antonella Ferro,
Daniele Generali,
Patrizia Vici,
Luigi Coltelli,
Alessandra Fabi,
Paolo Marchetti
and other authors.
,
Roberta Caputo,
Manuelita Mazza,
Mauro Mansutti,
Riccardo Masetti,
Zelmira Ballatore,
Rosalba Torrisi ,
Andrea Michelotti,
Alberto Zambelli,
Antonella Ferro,
Daniele Generali,
Patrizia Vici,
Luigi Coltelli,
Alessandra Fabi,
Paolo Marchetti
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 